
- Company
- Preventive Medicine Research Institute
- Role
- Founder & President
- Est. Net Worth
- $5 Million (Est.)
- Stage
- Emerging
- Industry
- Healthcare
Dean Ornish
Founder & President at Preventive Medicine Research Institute
About
Dean Ornish fundamentally changed the medical profession's approach to heart disease by proving through rigorous clinical research that comprehensive lifestyle changes — including a plant-based diet, moderate exercise, stress management, and social support — can actually reverse coronary artery disease without drugs or surgery. His research, published in leading medical journals including The Lancet and JAMA, was initially dismissed by the cardiology establishment but eventually led to Medicare covering his program — the first time the federal insurance program reimbursed a lifestyle intervention for heart disease. Ornish has served as a personal physician to multiple U.S. presidents and his Preventive Medicine Research Institute continues to produce research demonstrating that the same lifestyle program can slow or reverse the progression of early-stage prostate cancer and age-related cellular decline.
Current Company
Preventive Medicine Research Institute — Founder & President
The Doctor Who Proved Lifestyle Can Reverse Disease
Dean Ornish's career is built on a single, radical proposition: that the chronic diseases killing most Americans — heart disease, diabetes, and certain cancers — are not inevitable consequences of aging but the predictable results of how we live, and that changing how we live can not only prevent but actually reverse these conditions. His landmark 1990 study, published in The Lancet, demonstrated for the first time that comprehensive lifestyle changes — a low-fat, plant-based diet, moderate aerobic exercise, stress management through yoga and meditation, and group psychosocial support — could reverse coronary artery disease without drugs or surgery. Blockages that had been growing for decades actually shrank.
The medical establishment's initial reaction was skepticism verging on hostility. Cardiologists argued that patients would never comply with such demanding lifestyle changes and that the study's sample size was too small to be definitive. Ornish spent the next three decades addressing these objections through increasingly rigorous research, larger trials, and long-term follow-up studies. In 2010, Medicare agreed to cover the Ornish Program for Reversing Heart Disease — the first time the federal insurance program had ever reimbursed a lifestyle intervention. The decision validated decades of work and made Ornish's program accessible to millions of elderly Americans who couldn't afford it privately.
Beyond the Heart: Lifestyle Medicine as a New Paradigm
Ornish's research has extended beyond heart disease to demonstrate that the same lifestyle program can slow, stop, or reverse the progression of early-stage prostate cancer and can lengthen telomeres — the chromosomal markers associated with aging and disease. These findings, published in peer-reviewed journals, suggest that comprehensive lifestyle changes affect the body at a more fundamental level than any single intervention, influencing gene expression, inflammation, and cellular aging through mechanisms that researchers are still working to fully understand.
His six bestselling books, including 'Dr. Dean Ornish's Program for Reversing Heart Disease' and 'Undo It!,' have translated his clinical research into practical guidance for millions of readers. Ornish has served as a personal physician to multiple U.S. presidents and has advised corporations, health systems, and governments on implementing lifestyle medicine programs at scale. His most significant contribution may be philosophical rather than medical: he has argued persuasively that the American healthcare system's focus on treating disease after it appears — spending trillions on drugs, devices, and procedures — is not just inefficient but backwards, and that true healthcare reform requires reorienting the system toward keeping people healthy rather than profiting from their illness.